Article
Polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and risk of head and neck squamous cell carcinoma.
Brazilian journal of otorhinolaryngology - 1 Jan 2000
Rodrigues Juliana Olsen, Galbiatti Ana Lívia Silva, Ruiz Mariangela Torreglosa, Raposo Luiz Sergio, Maniglia José Victor, Pavarino-Bertelli Erika Cristina, Goloni-Bertollo Eny Maria
Abstract excerpt
UNLABELLED: Methylenetetrahydrofolate reductase gene (MTHFR) C677T polymorphism may be a risk factor for head and neck squamous cell carcinoma due to changes in folate levels that can induce disorders in the methylation pathway, which results in carcinogenesis. AIM: To evaluate MTHFR C677T polymorphism in patients with head and neck squamous cell carcinoma and in individuals with no history of cancer, and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
